Vasopressin vs placebo to reduce blood loss during myomectomy: Blood transfusion
Vasopressin probably leads to lower need for blood transfusion Participants who received blood transfusion compared with placebo to reduce blood loss during myomectomy (moderate certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Vasopressin vs placebo to reduce blood loss during myomectomy Need for blood transfusion Participants who received blood transfusion · Women with fibroids Vasopressin probably leads to lower need for blood transfusion Participants who received blood transfusion compared with placebo to reduce blood loss during myomectomy (moderate certainty). Interventions to reduce haemorrhage during myomectomy for fibroids (2014) · Cochrane Headline outcomes only | OR 0.15 [0.03, 0.74] | 2 studies · 90 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions to reduce haemorrhage during myomectomy for fibroids 2014 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.